Wyeth's new birth control pill expected to be approved

The FDA is expected to announce approval on Tuesday for Wyeth's birth control pill Lybrel, the first pill allowing women to avoid their monthly menstrual period indefinitely. Many doctors say there's no medical reason women need monthly bleeding and believe it causes health problems in women, including anemia and epilepsy. Still, some women raise concerns about whether blocking periods is safe or natural. Analysts have estimated that Lybrel sales could reach $40 million this year and $235 million by 2010. Shares of Wyeth hit a 52-week high of $58.49 on Monday.

Bonnie - it is so interesting that physician's stated for years that it's necessary for women to have menstrual periods. Now, new drugs and heavy marketing by drug companies have changed their minds. It always concerns me when humans try to improve upon mother nature.